Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 7, 2003Breast Cancer ResearchOpen Access

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

HYHiroko YamashitaMNMariko NishioTTTatsuya Toyama

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yamashita et al. (2003) studied this question.

synapsesocial.com/papers/6a1be1c2bc71fb1015a90cf6https://doi.org/10.1186/bcr738
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.1992 · 844 citations
  2. 2Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.1998 · 329 citations
  3. 3Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers1992 · 732 citations
  4. 4erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer1998 · 616 citations
  5. 5Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene1987 · 11,847 citations